OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Colchicine acts selectively in the liver to induce hepatokines that inhibit myeloid cell activation
Jui–Hsia Weng, Peter D. Koch, Harding H. Luan, et al.
Nature Metabolism (2021) Vol. 3, Iss. 4, pp. 513-522
Open Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

Targeting the NLRP3 inflammasome in cardiovascular diseases
Stefano Toldo, Eleonora Mezzaroma, Leo F. Buckley, et al.
Pharmacology & Therapeutics (2021) Vol. 236, pp. 108053-108053
Open Access | Times Cited: 193

Macrophage fumarate hydratase restrains mtRNA-mediated interferon production
Alexander Hooftman, Christian G. Peace, Dylan G. Ryan, et al.
Nature (2023) Vol. 615, Iss. 7952, pp. 490-498
Open Access | Times Cited: 129

GDF15 promotes weight loss by enhancing energy expenditure in muscle
Dongdong Wang, Logan K. Townsend, Geneviève J. DesOrmeaux, et al.
Nature (2023) Vol. 619, Iss. 7968, pp. 143-150
Open Access | Times Cited: 114

Low-Dose Colchicine for Secondary Prevention of Coronary Artery Disease
Kyle A. Nelson, Valentı́n Fuster, Paul M. Ridker
Journal of the American College of Cardiology (2023) Vol. 82, Iss. 7, pp. 648-660
Closed Access | Times Cited: 101

Inflammasome components as new therapeutic targets in inflammatory disease
Rebecca C. Coll, Kate Schroder
Nature reviews. Immunology (2024)
Closed Access | Times Cited: 23

Colchicine’s Role in Cardiovascular Disease Management
Leo F. Buckley, Peter Libby
Arteriosclerosis Thrombosis and Vascular Biology (2024) Vol. 44, Iss. 5, pp. 1031-1041
Closed Access | Times Cited: 22

Colchicine prevents accelerated atherosclerosis in TET2-mutant clonal haematopoiesis
María A. Zuriaga, Zhi Yu, Nuria Matesanz, et al.
European Heart Journal (2024)
Open Access | Times Cited: 17

GDF15 activates AMPK and inhibits gluconeogenesis and fibrosis in the liver by attenuating the TGF-β1/SMAD3 pathway
Javier Jurado-Aguilar, Emma Barroso, M. Bernard, et al.
Metabolism (2024) Vol. 152, pp. 155772-155772
Open Access | Times Cited: 16

Tumor-derived GDF-15 blocks LFA-1 dependent T cell recruitment and suppresses responses to anti-PD-1 treatment
Markus Haake, Beatrice Haack, Tina Schäfer, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 41

GDF15 increases insulin action in the liver and adipose tissue via a β-adrenergic receptor-mediated mechanism
Kim A. Sjøberg, Casper M. Sigvardsen, Abdiel Alvarado-Diaz, et al.
Cell Metabolism (2023) Vol. 35, Iss. 8, pp. 1327-1340.e5
Closed Access | Times Cited: 39

Overview of growth differentiation factor 15 (GDF15) in metabolic diseases
Jian Li, Xiangjun Hu, Zichuan Xie, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116809-116809
Open Access | Times Cited: 13

Increased hepatic gluconeogenesis and type 2 diabetes mellitus
Emma Barroso, Javier Jurado-Aguilar, Walter Wahli, et al.
Trends in Endocrinology and Metabolism (2024) Vol. 35, Iss. 12, pp. 1062-1077
Closed Access | Times Cited: 11

Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours
Ignacio Melero, María de Miguel Luken, Guillermo de Velasco, et al.
Nature (2024)
Open Access | Times Cited: 8

Coping With Stress: The Mitokine GDF-15 as a Biomarker of COVID-19 Severity
Darakhshan Sohail Ahmed, Stéphane Isnard, Carolina Berini, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 35

Activation of the transcription factor NRF2 mediates the anti-inflammatory properties of a subset of over-the-counter and prescription NSAIDs
Anna Eisenstein, Brandon K. Hilliard, Scott D. Pope, et al.
Immunity (2022) Vol. 55, Iss. 6, pp. 1082-1095.e5
Open Access | Times Cited: 35

Colchicine Inhibits NETs and Alleviates Cardiac Remodeling after Acute Myocardial Infarction
Yuewei Li, Sixu Chen, Ying Yang, et al.
Cardiovascular Drugs and Therapy (2022) Vol. 38, Iss. 1, pp. 31-41
Closed Access | Times Cited: 35

Colchicine Ameliorates Dilated Cardiomyopathy Via SIRT2‐Mediated Suppression of NLRP3 Inflammasome Activation
Xuan Sun, Junfeng Duan, Chenyi Gong, et al.
Journal of the American Heart Association (2022) Vol. 11, Iss. 13
Open Access | Times Cited: 34

Reference ranges for GDF-15, and risk factors associated with GDF-15, in a large general population cohort
Paul Welsh, Dorien M. Kimenai, Riccardo E. Marioni, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2022) Vol. 60, Iss. 11, pp. 1820-1829
Open Access | Times Cited: 34

The microtubule cytoskeleton: An old validated target for novel therapeutic drugs
Laurence Lafanéchère
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 31

Knocking on GDF15’s door for the treatment of type 2 diabetes mellitus
David Aguilar-Recarte, Emma Barroso, Xavier Palomer, et al.
Trends in Endocrinology and Metabolism (2022) Vol. 33, Iss. 11, pp. 741-754
Closed Access | Times Cited: 28

GDF15 is a major determinant of ketogenic diet-induced weight loss
Jun Lu, Mengqing Zhu, Bo Xia, et al.
Cell Metabolism (2023) Vol. 35, Iss. 12, pp. 2165-2182.e7
Open Access | Times Cited: 21

Localized delivery of anti-inflammatory agents using extracellular matrix-nanostructured lipid carriers hydrogel promotes cardiac repair post-myocardial infarction
Xinming Wang, Hongpeng Shi, Shixing Huang, et al.
Biomaterials (2023) Vol. 302, pp. 122364-122364
Closed Access | Times Cited: 17

Colchicine Blocks Abdominal Aortic Aneurysm Development by Maintaining Vascular Smooth Muscle Cell Homeostasis
Min Chen, Dafeng Yang, Yangzhao Zhou, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 6, pp. 2092-2110
Open Access | Times Cited: 6

GDF15 in Appetite and Exercise: Essential Player or Coincidental Bystander?
Anders B. Klein, Maximilian Kleinert, Erik A. Richter, et al.
Endocrinology (2021) Vol. 163, Iss. 1
Open Access | Times Cited: 38

Page 1 - Next Page

Scroll to top